过往新闻 March 1, 2021 The iQ Group Global celebrates 10 years of innovation Today marks a major milestone for The iQ… February 25, 2021 How the pandemic could change the way we fight cancer With all eyes on the global rollout of l… February 19, 2021 GBS Inc. Enters Sponsored Research Agreement with Johns Hopkins Bloomberg School of Public Health To Accelerate Development of Saliva-Based Diagnostic Tests New York, NY, February 18, 2021 – GBS In… ARCHIVE 国际报道 Dr George Syrmalis interview: ‘Calls for biotech investment rethink’ The iQ Group Global acquires new anticancer drug platform from University of Texas Scope for Saliva to Replace Blood in Diabetes Monitoring The iQ Group Global Introduces the Saliva Glucose Biosensor The iQ Group Global Developing Saliva-Based Glucose Test The Power of Practical Thinking: Dr George Syrmalis 媒体联络 与下面的我们的媒体代表联系。 AustraliaGemma Garkut+61 2 8239 5400gemma.garkut@theiqgroupglobal.com United StatesWeber Shandwick +1-212-546-7876kstravinskas@webershandwick.com
